CD274 and neoplasm: Recently, evidence shows that tumor-derived PGE2 promoted programmed cell death protein ligand 1 (PD-L1) expression on tumor-infiltrating myeloid cells and, therefore, plays an important role in tumor escape from anti-PD-L1 immunotherapies (204).